BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4596400)

  • 1. [Behavior of somatotropic hormone (HCH) after stimulation with L-arginine and L-Dopa in a subject operated for craniopharyngioma].
    Esposito V; Bellastella A; D'Alessandro B; Iacono G; Montano A
    Boll Soc Ital Biol Sper; 1973 May; 49(10):592-8. PubMed ID: 4596400
    [No Abstract]   [Full Text] [Related]  

  • 2. [Growth hormone stimulation with L. Dopa].
    Elkaïm R; Halimi S; Guidicelli C; Agnius-Delord C; Hadjian A; Perret J; Micoud M
    Nouv Presse Med; 1972 Mar; 1(10):675-7. PubMed ID: 4553974
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa.
    Pontiroli AE; Viberti GC; Tognetti A; Pozza G
    Horm Metab Res; 1976 Mar; 8(2):106-8. PubMed ID: 1261961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of plasmatic HGH after stimulation with L-Dopa in normal elderly subjects and in subjects with cerebrovascular disorders: preliminary study].
    Bellastella A; Cafaro MR; Colucci CF; D'Alessandro B; Gasbarro R
    Boll Soc Ital Biol Sper; 1973 May; 49(10):586-91. PubMed ID: 4788780
    [No Abstract]   [Full Text] [Related]  

  • 5. [Craniopharyngioma: renewed growth after the operation in spite of somatotropic hormone deficiency].
    Rosenberg D; David L; Bertrand J; Ruitton-Ugliengo A; Lapras C; Picot C; Monnet P
    Lyon Med; 1970 Apr; 223(16):847-57. PubMed ID: 5446108
    [No Abstract]   [Full Text] [Related]  

  • 6. [Craniopharyngioma. Recovery of growth after surgery in spite of somatotropin deficiency].
    Rosenberg D; David L; Bertrand J; Ruitton-Ugliego A; Lapras C; Picot C; Monnet P
    Arch Fr Pediatr; 1970 Apr; 27(4):355-69. PubMed ID: 4316181
    [No Abstract]   [Full Text] [Related]  

  • 7. Release of human growth hormone, follicle stimulating hormone, and luteinizing hormone in response to L-dihydroxy-phenylalanine (L-dopa) in normal man.
    Perlow MJ; Sassin JF; Boyar R; Hellman L; Weitzman ED
    Dis Nerv Syst; 1972 Dec; 33(12):804-10. PubMed ID: 4668972
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes of somatotropinemia in patients with acromegaly following administration of L-dopa].
    Chiodini PG; Liuzzi A; Cremascoli G; Botalla L
    Folia Endocrinol; 1973 Dec; 26(6):497-502. PubMed ID: 4801260
    [No Abstract]   [Full Text] [Related]  

  • 9. L-dopa induced growth hormone secretion. Comparison with insulin tolerance test, arginine infusion and sleep induced GH-secretion.
    Lucke C; Höffken B; Morgner KD
    Acta Endocrinol (Copenh); 1974 Oct; 77(2):241-9. PubMed ID: 4479561
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of L-dopa on anterior pituitary hormone release in man.
    Saito S; Abe K; Nagata N; Nakamura E; Tanaka K
    Endocrinol Jpn; 1972 Oct; 19(5):435-42. PubMed ID: 4678853
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Levodopa and L-arginine to test GH release in obesity.
    D'Allessandro B; Bellastella A; Esposito V; Gasbarro R
    N Engl J Med; 1974 Mar; 290(10):575. PubMed ID: 4811111
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of 1-dihydroxyphenylalanine (l-dopa), anesthesia and surgical stress on the secretion of growth hormone in the dog.
    Lovinger RD; Connors MH; Kaplan SL; Ganong WF; Grumbach MM
    Endocrinology; 1974 Nov; 95(5):1317-21. PubMed ID: 4426291
    [No Abstract]   [Full Text] [Related]  

  • 13. The advantages of combined stimulation by arginine and insulin in the study of the secretion of growth hormone.
    Ruitton A; Tell G; David M; Rocard E
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):846-54. PubMed ID: 4653986
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of L-dopa on plasma growth hormones and insulin.
    Kytomaki O; Nousiainen R; Pekkarinen A; Rinne U; Siirtola T; Sonninen V; Viljanen M
    Acta Neurol Scand Suppl; 1972; 51():125-6. PubMed ID: 4514338
    [No Abstract]   [Full Text] [Related]  

  • 15. [Levels of somatotropic hormone in plasma and growth changes in patients with cystic fibrosis].
    Rubio Pérez P; Sánchez Sánchez ML; Vila Canella T; Calvo Manuel E; Espinos Pérez D
    Rev Clin Esp; 1978 May; 149(3):229-32. PubMed ID: 694092
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tests of somatotropin reserve in obesity: response of GH to stimulation with L-DOPA and L-arginine].
    D'Alessandro B; Bellastella A; Esposito V; Gasbarro R
    Folia Endocrinol; 1974 Aug; 27(4):381-9. PubMed ID: 4408121
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison between various stimulation tests used for the study of somatotropic function in children].
    Donnadieu M; Combourieu M; Schimpff RM
    Pathol Biol (Paris); 1971 Mar; 19(5):293-301. PubMed ID: 4929992
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
    Ham JN; Ginsberg JP; Hendell CD; Moshang T
    Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intravenous L-dopa on growth hormone and luteinizing hormone levels in man.
    Souvatzoglou A; von Werder K; Bottermann P
    Acta Endocrinol (Copenh); 1973 Jun; 73(2):259-65. PubMed ID: 4740825
    [No Abstract]   [Full Text] [Related]  

  • 20. [Growth hormone, insulin, glucemia and plasmatic free fatty acids after arginine administration (author's transl)].
    Portugal-Alvarez J; Enríquez L; Zamarrón A; Vila T; Catalá E; Velasco-Martín A
    Rev Esp Fisiol; 1973 Dec; 29(4):289-91. PubMed ID: 4791170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.